Restless legs syndrome and pregnancy: A review

Parkinsonism and Related Disorders

Volumn 20, Issue 7, 2014, Pages

  Srivanitchapoom, Prachaya ^a,b   Pandey, Sanjay ^b,c   Hallett, Mark ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c G B PANT HOSPITAL   (India)

Author keywords

Hormones; Iron; Pregnancy; Restless legs syndrome

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ESTROGEN; FERROUS SULFATE; GABAPENTIN; GABAPENTIN ENACARBIL; IRON SACCHARATE; LEVODOPA; OXCARBAZEPINE; OXYCODONE; PLACEBO; PRAMIPEXOLE; PREGABALIN; PROGESTERONE; PROLACTIN; ROPINIROLE; ROTIGOTINE; THYROID HORMONE; TRAMADOL; ANTICONVULSIVE AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

DRUG EFFICACY; FOLATE METABOLISM; HORMONAL REGULATION; HUMAN; IRON METABOLISM; IRON THERAPY; NULLIPARA; PATHOPHYSIOLOGY; PREGNANCY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RESTLESS LEGS SYNDROME; REVIEW; THIRD TRIMESTER PREGNANCY; FEMALE; PREGNANCY COMPLICATIONS;

ANTICONVULSANTS; DOPAMINE AGENTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RESTLESS LEGS SYNDROME;

EID: 84902319299     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.03.027     Document Type: Review

References (82)

1. Walters AS, the International Restless Legs Syndrome Study Group Toward a better definition of the restless legs syndrome. Mov Disord 1995, 10:634-642.
2. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med 2003, 4:101-119.
3. Yeh P., Walters A.S., Tsuang J.W. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath 2012, 16:987-1007.
4. Ohayon M.M., O'Hara R., Vitiello M.V. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 2012, 16:283-295.
5. Ohayon M.M., Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. JPsychosom Res 2002, 53:547-554.
6. Sevim S., Dogu O., Kaleagasi H., Aral M., Metin O., Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. JNeurol Neurosurg Psychiatry 2004, 75:226-230.
7. Berger K., Luedemann J., Trenkwalder C., John U., Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004, 164:196-202.
8. Allen R.P., Walters A.S., Montplaisir J., Hening W., Myers A., Bell T.J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165:1286-1292.
9. Hadjigeorgiou G.M., Stefanidis I., Dardiotis E., Aggellakis K., Sakkas G.K., Xiromerisiou G., et al. Low RLS prevalence and awareness in central Greece: an epidemiological survey. Eur J Neurol 2007, 14:1275-1280.
10. Sevim S., Dogu O., Camdeviren H., Bugdayci R., Sasmaz T., Kaleagasi H., et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003, 61:1562-1569.
11. Lee H.B., Hening W.A., Allen R.P., Kalaydjian A.E., Earley C.J., Eaton W.W., et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. JNeuropsychiatry Clin Neurosci 2008, 20:101-105.
12. Chen N.H., Chuang L.P., Yang C.T., Kushida C.A., Hsu S.C., Wang P.C., et al. The prevalence of restless legs syndrome in Taiwanese adults. Psychiatry Clin Neurosci 2010, 64:170-178.
13. Pereira J.C., Pradella-Hallinan M., Lins Pessoa Hd Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics (Sao Paulo) 2010, 65:548-554.
14. Pereira J.C., Rocha e Silva I.R., Pradella-Hallinan M. Transient Willis-Ekbom's disease (restless legs syndrome) during pregnancy may be caused by estradiol-mediated dopamine overmodulation. Med Hypotheses 2013, 80:205-208.
15. Allen R.P., Earley C.J. Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset. Sleep Med 2000, 1:11-19.
16. Vogl F.D., Pichler I., Adel S., Pinggera G.K., Bracco S., De Grandi A., et al. Restless legs syndrome: epidemiological and clinicogenetic study in a South Tyrolean population isolate. Mov Disord 2006, 21:1189-1195.
17. Park Y.M., Lee H.J., Kang S.G., Choi H.S., Choi J.E., Cho J.H., et al. Prevalence of idiopathic and secondary restless legs syndrome in Korean women. Gen Hosp Psychiatry 2010, 32:164-168.
18. Goodman J.D., Brodie C., Ayida G.A. Restless legs syndrome in pregnancy. Br Med J 1988, 297:1101-1102.
19. Lee K.A., Zaffke M.E., Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. JWomens Health Gend Based Med 2001, 10:335-341.
20. Manconi M., Govoni V., De Vito A., Economou N.T., Cesnik E., Mollica G., et al. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004, 5:305-308.
21. Suzuki K., Ohida T., Sone T., Takemura S., Yokoyama E., Miyake T., et al. The prevalence of restless legs syndrome among pregnant women in Japan and the relationship between restless legs syndrome and sleep problems. Sleep 2003, 26:673-677.
22. Manconi M., Govoni V., De Vito A., Economou N.T., Cesnik E., Casetta I., et al. Restless legs syndrome and pregnancy. Neurology 2004, 63:1065-1069.
23. Wesstrom J., Nilsson S., Sundstrom-Poromaa I., Ulfberg J. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric 2008, 11:422-428.
24. Harano S., Hida T., Kaneita Y., Yokoyama E., Tamaki T., Takemura S., et al. Prevalence of restless legs syndrome with pregnancy and relationship with sleep disorders in the Japanese large population. Sleep Biol Rhythms 2008, 6:102-109.
25. Tunç T., Karadaǧ Y.S., Doǧulu F., Inan L.E. Predisposing factors of restless legs syndrome in pregnancy. Mov Disord 2007, 22:627-631.
26. Dzaja A., Wehrle R., Lancel M., Pollmächer T. Elevated estradoil plasma levels in women with restless legs during pregnancy. Sleep 2009, 32:169-174.
27. Alves D.A., Carvalho L.B., Morais J.F., Prado G.F. Restless legs syndrome during pregnancy in Brazilian women. Sleep Med 2010, 11:1049-1054.
28. Neau J.P., Marion P., Mathis S., Julian A., Godeneche G., Larrieu D., et al. Restless legs syndrome and pregnancy: follow-up of pregnant women before and after delivery. Eur Neurol 2010, 64:361-366.
29. Ismailogullari S., Ozturk A., Mazicioglu M.M., Serin S., Gultekin M., Aksu M. Restless legs syndrome and pregnancy in Kayseri, Turkey: a hospital based survey. Sleep Biol Rhythms 2010, 8:137-143.
30. Hübner A., Krafft A., Gadient S., Werth E., Zimmermann R., Bassetti C.L. Characteristics and determinants of restless legs syndrome in pregnancy: a prospective study. Neurology 2013, 80:738-742.
31. Sarberg M., Josefsson A., Wiréhn A.B., Svanborg E. Restless legs syndrome during and after pregnancy and its relation to snoring. Acta Obstet Gynecol Scand 2012, 91:850-855.
32. Pantaleo N.P., Hening W.A., Allen R.P., Earley C.J. Pregnancy accounts for most of the gender difference in prevalence of familial RLS. Sleep Med 2010, 11:310-313.
33. Taylor R.N., Lebovic D.I. The endocrinology of pregnancy. Greenspan's basic & clinical endocrinology 2007, 641-659. McGraw Hill. D.G. Gardner, D. Shoback (Eds.).
34. Becker J.B. Direct effect of l7β-Estradiol on striatum: sex differences in dopamine release. Synapse 1990, 5:157-164.
35. Cramer O.M., Parker R.C., Porter J.C. Estrogen inhibition of dopamine release into hypophysial portal blood. Endocrinology 1979, 104:419-422.
36. Shaw-Bruha C.M., Happe H.K., Murrin L.C., Rodriguez-Sierra J.F., Shull J.D. 17beta-Estradiol inhibits the production of dopamine by the tuberoinfundibular dopaminergic neurons of the male rat. Brain Res Bull 1996, 40:33-36.
37. Dluzen D.E., Ramirez V.D. Bimodal effect of progesterone on invitro dopamine function of the rat corpus striatum. Neuroendocrinology 1984, 39:149-155.
38. Kaufman S. Some metabolic relationships between biopterin and folate: implications for the "methyl trap hypothesis". Neurochem Res 1991, 16:1031-1036.
39. Bottiglieri T., Hyland K., Laundy M., Godfrey P., Carney M.W., Toone B.K., et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med 1992, 22:871-876.
40. Fenton V., Cavill I., Fisher J. Iron stores in pregnancy. Br J Haematol 1977, 37:145-149.
41. Walters A.S., Wagner M., Hening W.A. Periodic limb movements as the initial manifestation of restless legs syndrome triggered by lumbosacral radiculopathy. Sleep 1996, 19:825-826.
42. Aurora R.N., Kristo D.A., Bista S.R., Rowley J.A., Zak R.S., Casey K.R., et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults - an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012, 35:1039-1062.
43. Garcia-Borreguero D., Ferini-Strambi L., Kohnen R., O'Keeffe S., Trenkwalder C., Högl B., et al. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society. Eur J Neurol 2012, 19:1385-1396.
44. Davis B., Rajput A., Rajput M., Aul E., Eichhorn G. Arandomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 2000, 43:70-75.
45. Wang J., O'Reilly B., Venkataraman R., Mysliwiec V., Mysliwiec A. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med 2009, 10:973-975.
46. Earley C.J., Horska A., Mohamed M.A., Barker P.B., Beard J.L., Allen R.P. Arandomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009, 10:206-211.
47. Grote L., Leissner L., Hedner J., Ulfberg J. Arandomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome. Mov Disord 2009, 24:1445-1452.
48. Earley C.J., Heckler D., Allen R.P. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 2004, 5:231-235.
49. Ondo W.G. Intravenous iron dextran for severe refractory restless legs syndrome. Sleep Med 2010, 11:494-496.
50. Dostal M., Weber-Schoendorfer C., Sobesky J., Schaefer C. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series. Eur J Neurol 2012, 20:1241-1246.
51. Serikawa T., Shimohata T., Akashi M., Yokoseki A., Tsuchiya M., Hasegawa A., et al. Successful twin pregnancy in a patient with parkin-associated autosomal recessive juvenile parkinsonism. BMC Neurol 2011, 11:72. 10.1186/1471-2377-11-72.
52. Allain H., Bentue-Ferrer D., Milon D., Moran P., Jacquemard F., Defawe G. Pregnancy and parkinsonism. A case report without problem. Clin Neuropharmacol 1989, 12:217-219.
53. Cook D.G., Klawans H.L. Levodopa during pregnancy. Clin Neuropharmacol 1985, 8:93-95.
54. Hagell P., Odin P., Vinge E. Pregnancy in Parkinson's disease: a review of the literature and a case report. Mov Disord 1998, 13:34-38.
55. Benito-Leon J., Bermejo F., Porta-Etessam J. Pregnancy in Parkinson's disease: a review of the literature and a case report. Mov Disord 1999, 14:194.
56. Santamaria J., Iranzo A., Tolosa E. Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep. Sleep Med 2003, 4:153-155.
57. Boghen D. Successful treatment of restless legs with clonazepam. Ann Neurol 1980, 8:341.
58. Montagna P., Sassoli de Bianchi L., Zucconi M., Cirignotta F., Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand 1984, 69:428-430.
59. Boghen D., Lamothe L., Elie R., Godbout R., Montplaisir J. The treatment of the restless legs syndrome with clonazepam: a prospective controlled study. Can J Neurol Sci 1986, 13:245-247.
60. Saletu M., Anderer P., Saletu-Zyhlarz G., Prause W., Semler B., Zoghlami A., et al. Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. Eur Neuropsychopharmacol 2001, 11:153-161.
61. Lin A.E., Peller A.J., Westgate M.N., Houde K., Franz A., Holmes L.B. Clonazepam use in pregnancy and the risk of malformations. Birth Defects Res A Clin Mol Teratol 2004, 70:534-536.
62. Broussard C.S., Rasmussen S.A., Reefhuis J., Friedman J.M., Jann M.W., Riehle-Colarusso T., et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 2011, 204:314.e1-314.e11.
63. Meyer F.P., Rimasch H., Blaha B., Banditt P. Tramadol withdrawal in a neonate. Eur J Clin Pharmacol 1997, 53:159-160.
64. Willaschek C., Wolter E., Buchhorn R. Tramadol withdrawal in a neonate after long-term analgesic treatment of the mother. Eur J Clin Pharmacol 2009, 65:429-430.
65. Hartenstein S., Proquitte H., Bauer S., Bamberg C., Roehr C.C. Neonatal abstinence syndrome (NAS) after intrauterine exposure to tramadol. JPerinat Med 2010, 38:695-696.
66. O'Mara K., Gal P., DaVanzo C. Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol. Ann Pharmacother 2010, 44:1342-1344.
67. Happe S., Sauter C., Klosch G., Saletu B., Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology 2003, 48:82-86.
68. Garcia-Borreguero D., Larrosa O., de la Llave Y., Verger K., Masramon X., Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 2002, 59:1573-1579.
69. Kushida C.A., Becker P.M., Ellenbogen A.L., Canafax D.M., Barrett R.W. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS. Neurology 2009, 72:439-446.
70. Walters A.S., Ondo W.G., Kushida C.A., Becker P.M., Ellenbogen A.L., Canafax D.M., et al. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial. Clin Neuropharmacol 2009, 32:311-320.
71. Lee D.O., Ziman M.D., Perkins A.T., Poceta J.S., Walters A.S., Barrett R.W., et al. Arandomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. JClin Sleep Med 2011, 7:282-292.
72. Inoue Y., Hirata K., Uchimura N., Kuroda K., Hattori N., Takeuchi M. Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study. Curr Med Res Opin 2013, 29:13-21.
73. Fujii H., Goel A., Bernard N., Pistelli A., Yates L.M., Stephens S., et al. Pregnancy outcomes following gabapentin use: results of a prospective comparative cohort study. Neurology 2013, 80:1565-1570.
74. Garcia-Borreguero D., Larrosa O., Williams A.M., Albares J., Pascual M., Palacios J.C., et al. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study. Neurology 2010, 74:1897-1904.
75. Telstad W., Sørensen O., Larsen S., Lillevold P.E., Stensrud P., Nyberg-Hansen R. Treatment of the restless legs syndrome with carbamazepine: a double blind study. Br Med J (Clin Res Ed) 1984, 288:444-446.
76. Zucconi M., Coccagna G., Petronelli R., Gerardi R., Mondini S., Cirignotta F. Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment. Funct Neurol 1989, 4:263-271.
77. Hernández-Díaz S., Smith C.R., Shen A., Mittendorf R., Hauser W.A., Yerby M., et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012, 78:1692-1699. for the North American AED Pregnancy Registry, North American AED (Antiepileptic Drug) Pregnancy Registry, Scientific Advisory Committee, and North American AED Pregnancy Registry.
78. Jimenez-Trevino L. Oxcarbazepine treatment of restless legs syndrome: three case reports. Clin Neuropharmacol 2009, 32:169-170.
79. Trenkwalder C., Paulus W., Walters A.S. The restless legs syndrome. Lancet Neurol 2005, 4:465-475.
80. Uglane M.T., Westad S., Backe B. Restless legs syndrome in pregnancy is a frequent disorder with a good prognosis. Acta Obstet Gynecol Scand 2011, 90:1046-1048.
81. Cesnik E., Casetta I., Turri M., Govoni V., Granieri E., Strambi L.F., et al. Transient RLS during pregnancy is a risk factor for the chronic idiopathic form. Neurology 2010, 75:2117-2120.
82. Chen P.H., Liou K.C., Chen C.P., Cheng S.J. Risk factors and prevalence rate of restless legs syndrome among pregnant women in Taiwan. Sleep Med 2012, 13:1153-1157.